What's New

 

Since our beginning, we have been on the cutting edge of advances in treating some very common eye conditions. We have been involved in clinical trials that have led to approval of three major treatments for wet age-related macular degeneration, and we are now enrolling or will soon begin to enroll patients in three more studies.

Below is a list of all the studies which Retina Specialists are participating or have participated at Retina Specialists. Please call our office at 410-296-9748 for more information.


Current Studies

CURRENT CLINICAL STUDIES:

Age-related Macular Degeneration (Wet - Neovascularization)

OPT-302-1002/OPTHEA Phase IIb RECRUITING
LADDER/Genentech Phase III Upcoming
LADDER/Genentech Phase II Follow-up
CEDAR/Allergan Phase III Follow-up

Retinal Vein Occlusion

TOPAZ/Clearside Biomedical Phase III RECRUITING

Diabetic Macular Edema

MYL1701P-3001/Mylan GmbH Biosimilar Upcoming

PREVIOUS CLINICAL TRIALS:

Macular Degeneration (Wet)

CAPELLA/Regeneron Phase II
MAKO/Ohr Phase III
SOLARIS/Ophthotech Phase III
NEXUS/Lpath Phase II
CATT Follow-up/ National Eye Insitute Comparative Trial
VIEW-1 Extension/Regeneron Phase III
CATT/National Eye Institute Comparative Trial
COBALT/OPKO Phase III
LEVEL/OSI – EyeTech Phase IV
HORIZON/Genentech Open Label
SAILOR/Genentech Phase IIIb
ACUITY Phase I
CARE/Acuity Phase II
GENAERA 208/209 Phase II
GENAERA 301 Phase III
MARINA/Genentech Phase III
ANCHOR/Genentech Phase III

Macular Degeneration (Dry)

CLG561-2201/Alcon Proof of Concept
LAMPALIZUMAB/Genentech Phase III
OMASPECT/Genentech Extension Study
BAM114341/GlaxoSmithKline Phase II

Diabetic Retinopathy

PANORAMA/Regeneron Phase III
LUMINATE/Allegro Phase II
RISE/Genentech Phase III
DIAMOND/Macusight Phase II
PKC (MBDV)/Eli Lilly Open Label
PKC (MBCM)/Eli Lilly Phase III
RACE/Acuity Phase II

Nonclearing Vitreous Hemorrhage

Hyaluronidase/Advanced Corneal Phase III
Hyaluronidase/Advanced Corneal Phase II

Retinal Vein Occlusions

COPERNICUS/Regeneron Phase III
VIBRANT/Regeneron Phase III
Posurdex Study/Allergan Phase III

Click on this link for more information, and please contact our clinical coordinators at 410-296-9748 if you are interested in learning more about the latest clinical studies.